A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections

NCT01049438 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Methicillin Resistant Staphylococcus Aureus Skin Infections

Interventions

DRUG: nasal mupirocin
DRUG: topical 3% hexachlorophene body wash
DRUG: oral anti-MRSA antibiotic

Sponsor

Natividad Medical Center